203 Hydrocortisone as an intervention (RCT) 6 Supplemental table 3. Descriptive statistics of sleep outcomes measured with Actigraph Hydrocortisone Mean (SD) Placebo Mean (SD) Estimated effect (95%CI) Sleep Onset Latency (SOL) Min 22.7 (11.4) 21.7 (13.4) 1.60 (-1.39;4.59) Sleep Efficiency (SE) TST/TiB 76.6 (5.0) 76.9 (5.5) -0.15 (-1.63;1.34) Time in Bed (TiB) Min 669.3 (43.4) 656.8 (46.0) 10.23 (-5.00;25.45) Total Sleep Time (TST) Min 512.0 (41.4) 504.2 (42.1) 6.88 (-7.26;21.01) Wake After Sleep Onset (WASO) Min 134.6 (34.2) 130.9 (39.7) 1.62 (-9.35;12.59) Number of Awakenings (NA) N 30.0 (5.1) 28.2 (5.6) 1.62 (-0.29;3.54) Estimated effects are corrected for age, sex, start group (hydrocortisone/placebo), week of maintenance treatment, concomitant asparaginase treatment (yes/no). Abbreviations: 95%CI: 95% confidence interval, min: minutes, SD: standard deviation.
RkJQdWJsaXNoZXIy MTk4NDMw